[1]马存根, 刘淑璋, 王力声, 等乙肝患者T淋巴细胞亚群变化与血清HBV -DNA关系的观察[J]临床肝胆病杂志, 1994, 10 (1) ∶47
|
[2] ScullyLJ, DrownD , LloydC , etal.ImmunologicalstudysbeforeandduringinterferontherapyinchronicHBVinfection:identificationoffactorspredictingresponse[J]Hepatology, 1990, 12 (5) ∶1111-1117.
|
[3]李宝群慢性活动性乙型肝炎患者细胞亚群状态的研究[J]中国医科大学学报, 1990, 1∶43-45.
|
[4]YangPM , SuIJ, LaiMY .etal.Immunohistochemicalstudiesonin terahepaticlymphocyteinfiltratesinchronictypeBhepatiswithspe cialemphasisontheactivitionstatusofthelymphocytes[J]AmJGastroenterology, 1998, 83 (9) ∶948-953.
|
[5]王克霞, 王健, 张立华HBV侵入PBMC后对乙肝患者细胞免疫功能的影响[J]锦州医学院学报, 1998, 19 (3) ∶19
|
[6]彭文伟主编传染病学[M ]第5版, 北京人民卫生出版社2001P43
|
[7]ChingLungLai, ManFungYuen.profoundsuppressionofhepatitisBvirusreplicationwithlamivudine[J]JournalofMedicalVirology, 2000, 6 (3) ∶367-373.
|
[1] | Ding Tao, Wei Jian, He XuDong. Lamivudine antiviral treatment after radical surgery prolongs disease-free survival of patients with hepatitis B virus-related liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(8): 1497-1501. doi: 10.3969/j.issn.1001-5256.2017.08.017 |
[2] | Wang Wei, Zheng HuanWei, Ren GuiFang, Feng AiDong, Liu Lian, Li BingShun. Differential profiles of T-cell subsets are present in peripheral blood of patients with various progressive forms of hepatitis B infection[J]. Journal of Clinical Hepatology, 2013, 29(4): 276-279. |
[3] | Feng XianNi. The therapeutic efficacy of Mannatide Tablets in the treatment of Lamivudine-resistant chronic hepatitis B[J]. Journal of Clinical Hepatology, 2010, 26(2): 180-181. |
[4] | Yan ShuangHuan, Chen CuiYing, Cao ZhiChen, Liu JinXia. Changes in peripheral T-lymphocytes subsets and CD28 subsets in patients with chronic HBV infected[J]. Journal of Clinical Hepatology, 2009, 25(5): 328-330. |
[5] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[7] | Xin YongNing, Zhao Hong, Ji ZhiPing, Wan Ying, Bi QuanXin, Zhu XiaoLan. Therapeutic effect of combined therapy of hepatocyte growth-promoting factor and salviate milttiorrhize on chronic hepatitis B[J]. Journal of Clinical Hepatology, 2005, 21(1): 25-26. |
[8] | Zhang ZhaoHua, Qin LaiYing, Liu KuiHua, Wang Lei, Wang YaoZong. The Effects of Early Viral Response (EVR) on The Treatment of Chronic Hepatitis B with Lamivudine[J]. Journal of Clinical Hepatology, 2005, 21(3): 155-156. |
[9] | Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140. |
[10] | Liu Fang, Li XiuPing, Zhang SuHuan, Li BingShun, Liu JinXing. Influence of serum TGF-β1 on cellular immune function in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(6): 335-337. |
[14] | He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31. |